[{"address1": "121 Richmond Street West", "address2": "Penthouse Suite, 1300", "city": "Toronto", "state": "ON", "zip": "M5H2K1", "country": "Canada", "phone": "416 346 7764", "website": "https://www.psyencebiomed.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder PTSD, stress, grief, and adjustment disorder in the context of palliative care. It has a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer. The company has a strategic collaboration with PsyLabs to produce Ibogaine. The company is based in Toronto, Canada. Psyence Biomedical Ltd. operates as a subsidiary of Psyence Group Inc.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jody  Aufrichtig", "age": 50, "title": "Co-Founder, Executive Chairman & CEO", "yearBorn": 1974, "fiscalYear": 2025, "totalPay": 216667, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Warwick Ron Corden-Lloyd", "age": 44, "title": "Chief Financial Officer", "yearBorn": 1980, "fiscalYear": 2025, "totalPay": 195000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Neil  Maresky M.D.", "age": 60, "title": "Global Head of Clinical Development", "yearBorn": 1964, "fiscalYear": 2025, "totalPay": 390000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Taryn  Vos", "title": "General Counsel", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.513, "open": 2.43, "dayLow": 2.225, "dayHigh": 2.4915, "regularMarketPreviousClose": 2.513, "regularMarketOpen": 2.43, "regularMarketDayLow": 2.225, "regularMarketDayHigh": 2.4915, "payoutRatio": 0.0, "beta": 0.247, "trailingPE": 0.055316094, "volume": 102487, "regularMarketVolume": 102487, "averageVolume": 599153, "averageVolume10days": 216240, "averageDailyVolume10Day": 216240, "bid": 1.77, "ask": 2.9, "bidSize": 2, "askSize": 2, "marketCap": 4324437, "fiftyTwoWeekLow": 2.225, "fiftyTwoWeekHigh": 62.96, "allTimeHigh": 8730.0, "allTimeLow": 2.225, "fiftyDayAverage": 3.33216, "twoHundredDayAverage": 5.280545, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -5970532, "profitMargins": 0.0, "floatShares": 69843, "sharesOutstanding": 234280, "sharesShort": 130857, "sharesShortPriorMonth": 38264, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.5586, "heldPercentInsiders": 0.00184, "heldPercentInstitutions": 0.17074, "shortRatio": 0.09, "shortPercentOfFloat": 0.5586, "impliedSharesOutstanding": 1872051, "bookValue": 11.834, "priceToBook": 0.19520026, "lastFiscalYearEnd": 1743379200, "nextFiscalYearEnd": 1774915200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": 1011790, "trailingEps": 41.76, "lastSplitFactor": "125:1000", "lastSplitDate": 1746403200, "enterpriseToEbitda": 1.632, "52WeekChange": -0.94934213, "SandP52WeekChange": 0.12121439, "quoteType": "EQUITY", "currentPrice": 2.31, "recommendationKey": "none", "totalCash": 6135166, "totalCashPerShare": 86.083, "ebitda": -3658754, "totalDebt": 0, "quickRatio": 10.553, "currentRatio": 11.037, "returnOnAssets": -0.54196, "freeCashflow": -3394860, "operatingCashflow": -3734238, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PBM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1762563548, "regularMarketTime": 1762549201, "exchange": "NCM", "messageBoardId": "finmb_698500412", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -8.078, "regularMarketPrice": 2.31, "shortName": "Psyence Biomedical Ltd.", "longName": "Psyence Biomedical Ltd.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1639146600000, "postMarketChangePercent": -4.0476146, "postMarketPrice": 2.2165, "postMarketChange": -0.0934999, "regularMarketChange": -0.203, "regularMarketDayRange": "2.225 - 2.4915", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 599153, "fiftyTwoWeekLowChange": 0.08500004, "fiftyTwoWeekLowChangePercent": 0.038202267, "fiftyTwoWeekRange": "2.225 - 62.96", "fiftyTwoWeekHighChange": -60.649998, "fiftyTwoWeekHighChangePercent": -0.96331, "fiftyTwoWeekChangePercent": -94.93421, "epsTrailingTwelveMonths": 41.76, "fiftyDayAverageChange": -1.02216, "fiftyDayAverageChangePercent": -0.306756, "twoHundredDayAverageChange": -2.9705453, "twoHundredDayAverageChangePercent": -0.5625452, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-01-26", "cryptoTradeable": false, "displayName": "Psyence Biomedical", "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]